• Antifungal Imidazoles Target AdhE in Cryptosporidium parvum

  2026-07-12

  This study demonstrates that antifungal imidazoles are potent, low micromolar inhibitors of the bifunctional aldehyde/alcohol dehydrogenase (AdhE) enzyme in Cryptosporidium parvum. By elucidating a metabolic vulnerability and providing in vitro efficacy data, the research identifies a promising drug target for cryptosporidiosis and informs future inhibitor screening campaigns.

• Regorafenib (BAY 73-4506): Reliable Solutions in Cancer Biol

  2026-07-10

  This article addresses persistent laboratory challenges in cell viability and cancer models, demonstrating how Regorafenib (BAY 73-4506) (SKU A8236) offers reproducible, literature-backed solutions. Emphasizing protocol optimization, data interpretation, and vendor reliability, it guides researchers to leverage this multikinase inhibitor for advanced angiogenesis and tumor biology research.

• Influenza Hemagglutinin (HA) Peptide: Boosting IP Precision

  2026-07-09

  The Influenza Hemagglutinin (HA) Peptide from APExBIO sets a new benchmark for epitope tagging, enabling sensitive detection and robust elution of HA-tagged proteins. Discover optimized workflows, troubleshooting strategies, and the translational relevance of this HA tag peptide in advanced protein interaction studies.

• O-propargyl-puromycin (OPP): Precision in Protein Synthesis

  2026-07-09

  O-propargyl-puromycin (OPP) enables high-fidelity quantification of nascent protein synthesis in living cells, providing crucial insight into mitochondrial function and antibody production. This article delivers optimized workflows, troubleshooting strategies, and actionable guidance to maximize OPP’s impact in proteomics and immunology research.

• VX-745: Applied Workflows for Selective p38α MAPK Inhibition

  2026-07-08

  VX-745 empowers researchers to dissect inflammation and drug resistance by enabling precise, selective p38α MAPK inhibition. This article translates novel mechanistic insights into actionable workflows and troubleshooting strategies for advanced cellular and in vivo models.

• Miltefosine: Dual-Pathway Insights for Hematology Innovation

  2026-07-08

  Explore how Miltefosine, a PI3K/Akt signaling pathway inhibitor, uniquely modulates neutrophil differentiation via both PI3K/Akt and Ras/MEK/ERK pathways. This article provides advanced protocol guidance, practical interpretation of recent breakthroughs, and critical insights for hematology and translational research.

• Macrophage-Derived EV miR-660 Drives Breast Cancer Metastasi

  2026-07-07

  This study elucidates how tumor-associated macrophages (TAMs) promote breast cancer metastasis by transferring miR-660 via extracellular vesicles (EVs) to cancer cells, subsequently repressing KLHL21 and activating the IKKβ/NF-κB p65 pathway. These findings reveal a non-cell-autonomous mechanism of tumor progression and highlight new potential intervention points for cancer biology research.

• TSPAN18 Protects STIM1 to Drive Bone Metastasis in Prostate

  2026-07-07

  Zhou et al. (2023) identify TSPAN18 as a key regulator of bone metastasis in prostate cancer by stabilizing STIM1 and enhancing store-operated calcium entry. This mechanistic insight advances understanding of metastatic progression and highlights potential molecular targets for intervention.

• Ceftolozane Sulfate: Optimizing PK/PD Assays Against P. aeru

  2026-07-06

  Ceftolozane sulfate from APExBIO empowers robust, resistance-aware antibacterial research through high-purity, reproducible performance in both in vitro susceptibility testing and translational PK/PD assays. This guide details advanced workflows, troubleshooting, and practical integration of key findings from recent multicenter studies to maximize experimental reliability against Pseudomonas aeruginosa and resistant Enterobacterales.

• Isoprenaline Hydrochloride: Advanced Workflows for Cardiac R

  2026-07-06

  Isoprenaline Hydrochloride (isoproterenol) enables precise modeling of β-adrenergic signaling in both cardiac and neurovascular research. This guide delivers stepwise protocols, troubleshooting strategies, and insights from recent heart–brain axis studies, positioning APExBIO’s high-purity product as essential for translational and mechanistic discoveries.

• N6-Methyl-dATP: Epigenetic Nucleotide Analog for Fidelity St

  2026-07-05

  N6-Methyl-dATP is a methylated deoxyadenosine triphosphate analog that enables precise probing of DNA replication fidelity and methylation-driven regulation. Its N6 methyl modification alters polymerase recognition and supports advanced genomic stability research. APExBIO's B8093 formulation provides ≥90% purity for robust molecular biology workflows.

• Comprehensive Mutational Profiling in Myeloma Cell Lines: In

  2026-07-04

  This study presents the first exome-wide characterization of genetic mutations in human multiple myeloma cell lines (HMCLs), revealing both known and novel driver genes associated with tumor progression and drug resistance. Its findings serve as a resource for model selection in mechanistic and translational research, fostering precision strategies for studying myeloma biology and therapeutic response.

• D-Luciferin: Optimizing Firefly Luciferase Substrate Workflo

  2026-07-03

  D-Luciferin enables ultrasensitive, non-invasive bioluminescence imaging and ATP quantification in live cells and animal models. This guide details advanced applied use-cases, protocol enhancements, and troubleshooting steps that maximize the reliability and specificity of firefly luciferase-based assays, including innovations inspired by targeted gene-silencing studies in glioblastoma.

• MRE11:p.K464R Mutation Drives Olaparib Resistance in HGSOC

  2026-07-03

  Zhuang et al. reveal that the MRE11:p.K464R mutation confers resistance to the PARP inhibitor olaparib in high-grade serous ovarian cancer (HGSOC) by enhancing DNA damage repair via strengthened protein interactions. These findings highlight the mutation as a promising biomarker for resistance monitoring and suggest new avenues for overcoming therapeutic resistance.

• Cholesterol Impedes Lipid Nanoparticle Trafficking for DNA D

  2026-07-02

  The referenced study reveals that elevated cholesterol content in lipid nanoparticles (LNPs) causes their entrapment in peripheral early endosomes, impeding effective intracellular trafficking and nucleic acid cargo delivery. These mechanistic insights refine our understanding of LNP formulation parameters crucial for optimizing nonviral gene transfer platforms.

456 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page